Psychotic Disorders
📧 Sign up to get email alerts when something new happens for Psychotic Disorders.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2013-01-03Clinical Trial Update: A Usability Study of a Smoking Cessation Decision Aid in People With a Recent First Episode of Psychosis [NA]
This completed usability study evaluated a smoking-cessation decision aid in people with a recent first episode of psychosis.
-
CLINICAL_TRIALS trial_result · 2012-12-07Clinical Trial Update: A Study of Treatment Success in Changing From Olanzapine to Long-acting Injectable Risperidone (RISPERDAL® CONSTA™) [Phase 4]
Phase 4 study evaluating treatment success when switching patients with schizophrenia or psychotic disorders from oral olanzapine to the lon…
-
CLINICAL_TRIALS trial_result · 2012-04-03Clinical Trial Update: Effect of Antipsychotics on Appetite Regulation
A completed clinical trial examined the effect of antipsychotics on appetite regulation in people with psychotic disorders.
-
CLINICAL_TRIALS trial_result · 2012-02-15Clinical Trial Update: A United States Study of Corlux for Psychotic Symptoms in Psychotic Major Depression [Phase 3]
Phase 3 US study of Corlux for psychotic symptoms in psychotic major depression has completed.
-
CLINICAL_TRIALS trial_result · 2012-02-15Clinical Trial Update: A United States Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major Depression [Phase 3]
Phase 3 US study evaluating the safety and tolerability of Corlux for psychotic symptoms in psychotic major depression has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-02-15Clinical Trial Update: An International Extension Study of Corlux for Recurrent Psychotic Symptoms in Psychotic Major Depression [Phase 3]
An international extension study of Corlux (mifepristone) in recurrent psychotic symptoms of psychotic major depression (Phase 3), with comp…
-
CLINICAL_TRIALS trial_result · 2011-12-30Clinical Trial Update: Critical Time Intervention in the Transition From Hospital to Community in People With Severe Mental Illness [NA]
The document reports a completed clinical trial evaluating Critical Time Intervention to help people with severe mental illness transition f…
-
FDA approval · 2011-09-13FDA Approved: CHLORPROMAZINE HYDROCHLORIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for chlorpromazine hydrochloride from Upsher-Smith Laboratories, signaling an approved update to the…
-
FDA approval · 2011-09-02FDA Approved: HALOPERIDOL — Original Application (Sagent Pharmaceuticals)
FDA approved HALOPERIDOL lactate injectable as an Original Application by Sagent Pharmaceuticals. This adds a generic HALOPERIDOL lactate pr…
-
CLINICAL_TRIALS research · 2011-08-26Clinical Trial Update: Epidemiology Study of Psychosis
A clinical trial update on an epidemiology study of psychosis conducted by The University of Hong Kong; current status is UNKNOWN.
-
CLINICAL_TRIALS trial_result · 2011-06-17Clinical Trial Update: Melperone (an Anti-Psychotic) in Patients With Psychosis Associated With Parkinson's Disease [Phase 2]
Phase 2 trial evaluating melperone for psychosis in Parkinson's disease has completed, with results posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: A Study of the Effectiveness and Safety of Risperidone in the Treatment of Adolescents With Schizophrenia [Phase 3]
A Phase 3 trial evaluating the effectiveness and safety of risperidone in adolescents with schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2011-05-17Clinical Trial Update: Treatment With Risperidone Long Acting Injectable (RLAI) in an Early Phase of Psychosis [Phase 4]
This document reports the completion of a Phase 4 trial evaluating risperidone long-acting injectable in early psychosis.
-
CLINICAL_TRIALS research · 2011-05-16Clinical Trial Update: Mental Health Related to School Dropout in Luxembourg
A clinical trial update from Luxembourg investigates mental health factors related to school dropout and lists several psychiatric condition…
-
CLINICAL_TRIALS trial_result · 2011-02-11Clinical Trial Update: A Study of the Effectiveness and Safety of Risperidone Compared With Haloperidol and Placebo in Patients With Chronic Schizophrenia [Phase 3]
Phase 3 trial assessing the effectiveness and safety of risperidone compared with haloperidol and placebo in chronic schizophrenia; the stud…
-
CLINICAL_TRIALS trial_result · 2011-01-26Clinical Trial Update: Fast Titration Of Quetiapine Versus Currently Approved Titration [Phase 3]
A Phase 3 trial comparing fast titration of quetiapine to the approved titration schedule in psychotic disorders has completed.
-
CLINICAL_TRIALS trial_result · 2011-01-25Clinical Trial Update: Specialized Addiction Treatment Versus Treatment as Usual for Young Patients With Cannabis Abuse and Psychosis [NA]
A completed clinical trial comparing specialized addiction treatment versus treatment as usual for young patients with cannabis use disorder…
-
CLINICAL_TRIALS trial_result · 2011-01-10Clinical Trial Update: A Study to Assess Safety and Tolerabiltiy Associated With a Switch From Oral Antipsychotic Medications to Long-acting Injectable Risperidone in Patients With Schizophrenia. [Phase 3]
A Phase 3 study evaluated the safety and tolerability of switching from oral antipsychotics to a long-acting injectable form of risperidone …
-
CLINICAL_TRIALS trial_result · 2011-01-04Clinical Trial Update: Treatment of Schizophrenia With an Omega-3 Fatty Acid (EPA) and Antioxidants [Phase 2, Phase 3]
An update on Phase 2 and Phase 3 trials evaluating whether omega-3 fatty acid EPA, combined with antioxidants, can treat schizophrenia and r…
-
CLINICAL_TRIALS research · 2010-12-10Clinical Trial Update: FAST-A Study to Evaluate the Efficacy and Safety of Quetiapin IR in Patients With Acute Psychosis [Phase 3]
A Phase 3 clinical trial (FAST-A) evaluating the efficacy and safety of Quetiapin IR in acute psychosis was terminated.
-
FDA approval · 2010-12-06FDA Approved: HALOPERIDOL — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for haloperidol submitted by Zydus Lifesciences Limited.
-
CLINICAL_TRIALS trial_result · 2010-12-03Clinical Trial Update: A Study of the Effectiveness and Safety of Long-acting Injectable Risperidone Versus Placebo in the Treatment of Patients With Schizophrenia [Phase 3]
Phase 3 trial comparing long-acting injectable risperidone with placebo in schizophrenia reports effectiveness and safety data.
-
FDA approval · 2010-12-03FDA Approved: CHLORPROMAZINE HYDROCHLORIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for chlorpromazine hydrochloride from Upsher-Smith Laboratories, indicating an updated regulatory ac…
-
CLINICAL_TRIALS trial_result · 2010-10-18Clinical Trial Update: RiSPECT: Risperdal Safety Protocol Evaluation Consta Treatment, a Post Authorization Safety Survey to Obtain Information on the Safety and Efficacy of Risperidone When Used in Routine Clinical Practice
This document reports a completed post-authorization safety study (RiSPECT) evaluating the safety and effectiveness of risperidone used in r…
-
CLINICAL_TRIALS research · 2010-09-15Clinical Trial Update: Optimal Duration of Early Intervention for Psychosis [NA]
Clinical trial update on the optimal duration of early intervention for psychosis conducted by The University of Hong Kong; the trial status…